Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20101
20111
20122
20142
20161
20181
20191
20204
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto4
argenx3
GlaxoSmithKline2
Novartis Pharmaceuticals2
Rigel Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Amgen1
CSL Behring1
European Research Consortium on ITP1
Fondazione Progetto Ematologia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic22
Thrombocytopenia4
Purpura2
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1
Blood Platelet Disorders1
Fatigue1
Hemorrhage1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.